Research Article
Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
Table 6
PWV according to treatment protocols.
| | Mean ± SD | |
| Operation | Lumpectomy () | 7.2 ± 1.2 | 0.503 | Modified radical mastectomy () | 7.4 ± 1.3 | | Radiotherapy | Yes () | 7.2 ± 1.2 | 0.076 | No () | 8.2 ± 1.0 | | Chemotherapy | Anthracycline + trastuzumab | 7.6 ± 1.0 | 0.428 | Anthracycline + taxane + trastuzumab | 7.2 ± 1.3 | | Hormonotherapy | Yes () | 7.4 ± 1.2 | 0.434 | No () | 7.0 ± 1.4 | | Hormonotherapy type | Tamoxifen () | 6.5 ± 0.7 | <0.01 | Aromatase inhibitor () | 8.3 ± 0.9 | |
|
|
EC: epirubicin + cyclophosphamide; FEC: fluorouracil + Epirubicin + Cyclophosphamide.
|